Testing effectiveness (Phase 2)Study completedNCT04312997
What this trial is testing
The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection
Who this might be right for
COVID-19
Pulmotect, Inc. 101